Stock Events

Stock Events

UroGen Pharma (URGN) Q2 2026 Earnings

6MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.05

-0.86

-0.66

-0.47

Details

Expected EPS

-0.482438

Actual EPS

-0.47

Surprise EPS

0.01

Surprise Percent

+2.58%

Description

UroGen Pharma (URGN) has reported earnings of -0.47 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.